PATENT CLAIM ANALYSIS

Application Number: 16017713
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "426000"]

Abstract:
Disclosed herein are methods of treating venous thrombosis and vascular inflammation through administration of carbon monoxide and/or a carbon monoxide releasing molecule. Also disclosed herein are devices capable of releasing carbon monoxide for the purpose of treating microvascular, arterial and venous thromboembolism and/or inflammation.

Claim (Index 8):
The method  claim 1 , wherein the CO and/or CORM or pharmaceutically acceptable salt thereof is administered by inhalation, by infusion, by injection, enterically, intraperitoneally, or topically; optionally wherein the CORM is encased in a nanoparticle or nanodisk; and optionally wherein the nanoparticle or nanodisk comprises biodegradable polylactic acid (\u201cPLA\u201d), biodegradable polyglycolic acid (\u201cPGA\u201d), biodegradable poly(lactic-co-glycolic acid) (\u201cPGLA\u201d), or a combination thereof, or the nanoparticle is a liposome.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 94.0
- Lexical Diversity: 1.51613
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11793820', '13501278', '14253750', '15232773', '15736933']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.741196660937663
- 35 USC 102 Novelty (BERT): 0.5071823148605571
- Combined Prediction Score: 0.7177952263299524
- Mean Citation Score: 229.541116
- Max Citation Score: 244.04114
- Similarity Product: 157.59045008544444

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test